Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi-Aventis To Buy Acambis | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi-Aventis To Buy Acambis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi-Aventis has offered $550 million to buy out UK-based vaccine maker Acambis. Acambis’ board has agreed to the acquisition. Sanofi’s vaccine division, Sanofi Pasteur, has worked with Acambis for more than a decade and is currently partnered with it for three projects.

Sanofi Pasteur president and chief executive officer Wayne Pisano remarked, “We are delighted that the board of Acambis has unanimously agreed to recommend our proposed acquisition. This mutually beneficial acquisition is a logical step building upon Sanofi Pasteur and Acambis’ decade long partnership on key projects to develop and market vaccines of the future. Acambis’ skilled workforce made of individuals who share our passion for vaccines and prevention of diseases will contribute to our future success. We look forward to welcoming them into Sanofi Pasteur’s innovation driven organization.”
 
Acambis markets a smallpox vaccine to the U.S. government and has several other late-stage programs in place, targeting Japanese encephalitis, dengue and West Nile virus, along with several other early-stage programs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters